Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06580509 · ClinicalTrials.gov registry record · Early Phase 1
TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study
A Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
NCT06580509 is a Early Phase 1 study that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 12 participants.
The verdict
NCT06580509, a Early Phase 1 study, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
After a child has their tonsils removed, sometimes they might bleed which can be a problem. There is a special mist medicine called nebulized tranexamic acid (TXA) that might help stop the bleeding without having to touch the sore spot. If this mist works well, it could help kids get better by making sure they don't have to go back for more surgery or need blood from someone else. Not having another surgery is good because it means kids won't have to sleep under medicine again, which can sometimes be risky for their brains and breathing, and they won't feel as scared or hurt.
Interventions
- OTHER Normal Saline
- DRUG Tranexamic Acid Injectable Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-02-18 |
| Est. Completion | 2028-09-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06580509
The ClinicalTrials.gov registry entry for NCT06580509 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT06580509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06580509 about?
NCT06580509 is a clinical study titled "TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study". After a child has their tonsils removed, sometimes they might bleed which can be a problem. There is a special mist medicine called nebulized tranexamic acid (TXA) that might help stop the bleeding without having to touch the sore spot. If this mist works well, it could help kids get better by makin...
What is the current status of trial NCT06580509?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2026-02-18. Estimated completion is 2028-09-30.
What interventions are being tested in trial NCT06580509?
The interventions under investigation include: Normal Saline (OTHER), Tranexamic Acid Injectable Product (DRUG).
Who is sponsoring clinical trial NCT06580509?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.